Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

This New Jersey bill (A 864) classifies xylazine - a sedative often misused in illicit drug mixtures - as a Schedule III controlled substance under state law, except when used by veterinarians for animal treatment. Schedule III means it has accepted medical use but potential for abuse leading to moderate dependence, subjecting unauthorized use to criminal penalties. Specifically, illegal possession, distribution, or use of xylazine would be a third-degree crime, punishable by 3-5 years in prison and fines up to $35,000, with enhanced penalties near schools or for distributing to minors. The bill directly affects individuals misusing xylazine (including in human drug use) and law enforcement, while exempting veterinary medical use.